Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Oct 28, 2026
TickeronGET DAILY SIGNALS
SCHD vs VYM: Quality Screening Meets Broad Dividend Yield Exposure

SCHD vs VYM: Quality Screening Meets Broad Dividend Yield Exposure

Key Takeaways

  • SCHD tracks the Dow Jones U.S. Dividend 100 Index with roughly 100 holdings, while VYM tracks the FTSE High Dividend Yield Index with more than 600 holdings, giving VYM materially broader diversification.
  • SCHD emphasizes quality, dividend-growth, and cash-flow screens, tilting heavily toward consumer staples, healthcare, and energy; VYM is market-cap weighted with a heavier financials and technology allocation.
  • Both funds are passively managed and low cost, but VYM's 0.04% expense ratio is slightly cheaper than SCHD's 0.06%.
  • VYM's largest position, Broadcom (AVGO), injects meaningful semiconductor exposure, whereas SCHD's largest positions are defensive pharmaceutical and staples names.
  • SCHD tends to offer a higher distribution yield with a quality-growth tilt, while VYM provides broader sector exposure and lower concentration risk.
  • Their relative positioning reflects two different philosophies of income investing: disciplined quality screening versus broad market-cap-weighted yield capture.

Introduction

SCHD and VYM rank among the most popular dividend-focused ETFs for U.S. investors seeking steady income from large-cap equities. They pursue a similar objective yet follow distinct approaches. SCHD applies strict fundamental screens for dividend sustainability and cash flow strength, while VYM takes a wider view across higher-yielding stocks. Understanding these differences in holdings, sectors, costs, and risk profiles helps clarify which might fit a given income portfolio.

Schwab U.S. Dividend Equity ETF (SCHD) Overview

SCHD tracks the Dow Jones U.S. Dividend 100 Index through a rules-based process that favors companies with consistent dividend histories, solid cash-flow-to-debt ratios, and attractive yields. The result is a concentrated portfolio of about 100 holdings, weighted by market cap with concentration limits. This produces a tilt toward resilient large-cap value names in consumer staples, healthcare, and energy.

Recent top holdings have included Merck & Co. (MRK), Abbott Laboratories (ABT), Amgen (AMGN), Coca-Cola (KO), Chevron (CVX), ConocoPhillips (COP), Procter & Gamble (PG), Verizon Communications (VZ), UnitedHealth Group (UNH), The Home Depot (HD), Texas Instruments (TXN), and PepsiCo (PEP). I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. The fund maintains a 0.06% expense ratio and pays distributions quarterly, with its defensive bias often linked to lower volatility than the broader market.

Vanguard High Dividend Yield ETF (VYM) Overview

VYM follows the FTSE High Dividend Yield Index by selecting companies with above-average forecast yields, excluding REITs, and weighting by market capitalization. This simpler methodology yields a much larger portfolio, typically more than 600 holdings, with limited single-stock risk.

Recent top positions have featured Broadcom (AVGO), JPMorgan Chase (JPM), Exxon Mobil (XOM), Johnson & Johnson (JNJ), AbbVie (ABBV), Cisco Systems (CSCO), Bank of America (BAC), Chevron (CVX), Merck & Co. (MRK), and Caterpillar (CAT). Financials represent the largest sector at roughly 21%, followed by technology and healthcare. The inclusion of Broadcom (AVGO) adds notable semiconductor exposure. VYM carries a 0.04% expense ratio and distributes income quarterly.

Industry and Thematic Backdrop

Both ETFs sit within the large-cap dividend space, where interest-rate movements, sector rotations, and yield-seeking behavior shape performance. Elevated Treasury yields can pressure dividend equities relative to fixed income, while falling rates often draw capital back. SCHD’s healthcare and staples holdings tend to respond to defensive demand, whereas VYM’s financials exposure reacts to yield-curve dynamics and credit conditions. Energy names in each add commodity-price sensitivity, and VYM’s technology weighting introduces growth-cycle influences.

Performance and Positioning Comparison

Over recent cycles, the funds have shown distinct return and volatility characteristics tied to their sector weights. SCHD’s focus on staples, healthcare, and energy has generally supported steadier, lower-beta behavior. VYM’s larger financials and technology allocations have made it more sensitive to cyclical and growth rotations, especially with strength in its top semiconductor holding. In quality-focused environments, SCHD’s screens have often provided resilience; in periods favoring financials or broad technology gains, VYM’s market-cap approach has offered relative advantages. The two remain complementary rather than interchangeable for most income portfolios.

Using Tickeron Tools for Deeper Analysis

Throughout my review of these holdings and sector tilts, Tickeron’s AI-powered tools provided quick cross-checks on comparable names and technical patterns. This helped confirm how the structural differences between the two ETFs might play out under varying market conditions.

Exploring Broader Opportunities with Tickeron AI Screener

Tickeron’s AI Screener has become a regular part of my workflow when comparing dividend ETFs like these. It lets me apply custom filters for fundamentals, technical patterns, volatility, and AI signals across thousands of securities, surfacing ideas that align with specific income or risk criteria far faster than manual methods. I typically run quick scans on sector exposures and holdings overlap before finalizing allocation decisions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHD, VYM

SCHD sees MACD Histogram crosses below signal line

SCHD saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 37 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SCHD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 29 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHD as a result. In 50 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

SCHD moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 84%.

Following a +1.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 265 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

SCHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 285 of 363 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Notable companies

The most notable companies in this group are Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), PepsiCo (NASDAQ:PEP), Abbott Laboratories (NYSE:ABT).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF (SCHD) ETF is 57.94B. The market cap for tickers in the group ranges from 363.12M to 417.06B. CVX holds the highest valuation in this group at 417.06B. The lowest valued company is AMSF at 363.12M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was -6%. For the same ETF, the average monthly price growth was -2%, and the average quarterly price growth was 5%. GIS experienced the highest price growth at 4%, while VRTS experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 58%. For the same stocks of the ETF, the average monthly volume growth was 35% and the average quarterly volume growth was 17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 42
Price Growth Rating: 48
SMR Rating: 42
Profit Risk Rating: 60
Seasonality Score: 9 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.